Abstract
Objective:
As for other auto-immune processes, thyroiditis is monitored after vaccinations. The aim was to estimate the baseline incidence of thyroiditis among girls, before investigating papillomavirus vaccination as a potential risk factor.
Methods:
Observational cohort study including girls aged 9-18 years and registered between 2002-2016 in the Spanish Primary Care Database for Pharmacoepidemiological Research. Girls were followed until a thyroiditis occurred, 19 years of age, left the cohort, died, or the study ended. Anonymized records were reviewed for diagnosis confirmation (endocrine discharge letter and/or free-text comments) in a random sample. Incidence rate (IR) per 105 person years (/105 py) was estimated.
Results:
The cohort numbered 480,169 girls, of whom 641 had a record of thyroiditis: 346 autoimmune thyroiditis; 17 thyroiditis of other types; and 278 unspecified. Incidence of recorded thyroiditis increased with age, from 23.96 at age 9 years to 47.91 at age 14 years, and stabilized around 31.06-34.43 among girls aged 15-18 years. Of the 98 records reviewed, 60.2% were ‘confirmed’ cases, 32.7% ‘possible’ and 7.1% were discarded. After correction for discarded cases, IR=20.83 ‘confirmed’ cases, increasing to 32.12/105 py when ‘confirmed’ plus ‘possible’ cases were included. Between 2002-2005, incidences were lower (16.28 and 20.93 cases/105 py) than in the period 2007-2016 (21.17 and 33.78 cases/105 py) for ‘confirmed’ and ‘confirmed’ plus ‘possible’, respectively.
Conclusion:
Two-thirds of the recorded thyroiditis included confirmatory evidence. The incidence of thyroiditis among girls increased with age and in the later period, and remained stable among girls aged 15-18 years.
Keywords: Thyroiditis, women, incidence, precision of recording, International Classification of Primary Care codes, ICD-9 codes, primary care electronic records, paediatric thyroid disease
Read the full text
6 sections · 5 figures · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Diab N, Daya NR, Juraschek SP, Martin SS, McEvoy JW, Schultheiß UT, Köttgen A, Selvin E. Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community. Sci Rep 2019;9:13156.
Sulejmanovic M, Cickusic AJ, Salkic S, Bousbija FM. Annual Incidence of Thyroid Disease in Patients Who First Time Visit Department for Thyroid Diseases in Tuzla Canton. Mater Sociomed 2019;31:130-134.
Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014;99:923-931. Epub 2014 Jan 1
Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol 2013;5(Suppl 1):45-49. Epub 2012 Nov 15
Liliana R Santos, Paulo Fonseca, Rita Cardoso, Paula Soares. Hashimoto’s Thyroiditis in Adolescents. Eur Endocrinol 2016;12:85-88.
Maciá-Martínez MA, Gil M, Huerta C, Martín-Merino E, Álvarez A, Bryant V, Montero D; BIFAP Team. Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain. Pharmacoepidemiol Drug Saf 2020;29:1236-1245. Epub 2020 Apr 26
Porcentaje de población cubierta por el sistema sanitario publico. Encuesta Nacional de Salud. MSSSI/INE. Indicadores clave [Internet]. Sistema Nacional de Salud; 2018 Jun. Available from: http://inclasns.msssi.es/main.html
ICPC-2. International classification of primary care. Second Edition. Oxford, Oxford University Press, 1998.
International classification of diseases : [9th] ninth revision, basic tabulation list with alphabetic index [Internet]. World Health Organization; 1978 [cited 2017 Sep 26]. Available from: http://www.who.int/iris/handle/10665/39473
The Spanish Agency of Medicines and Medical Devices. BIFAP (Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria) [Internet]. [cited 2021 Apr 16]. Available from: http://bifap.aemps.es/
Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J 2018;7:167-186. Epub 2018 Jul 25
Bollaerts K, Rekkas A, De Smedt T, Dodd C, Andrews N, Gini R. Disease misclassification in electronic healthcare database studies: Deriving validity indices-A contribution from the ADVANCE project. PloS One 2020;15:e0231333.
Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, Emery M, Liaw KL, Jacobsen SJ. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med 2012;271:193-203. Epub 2011 Nov 15
Yanai H, Hakoshima M, Katsuyama H. Differences in Clinical and Laboratory Findings Among Graves’ Disease, Painless Thyroiditis and Subacute Thyroiditis Patients With Hyperthyroidism. J Endocrinol Metab 2019;9:37-42.
Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician 2006;73:1769-1776.
Persani L, Brabant G, Dattani M, Bonomi M, Feldt-Rasmussen U, Fliers E, Gruters A, Maiter D, Schoenmakers N, van Trotsenburg ASP. 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J 2018;7:225-237. Epub 2018 Jul 19
Willame C, Rosillon D, Zima J, Angelo MG, Stuurman AL, Vroling H, Boggon R, Bunge EM, Pladevall-Vila M, Baril L. Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Hum Vaccines Immunother 2016;12:2862-2871. Epub 2016 Jul 18
Léger J, Oliver I, Rodrigue D, Lambert A-S, Coutant R. Graves’ disease in children. Ann Endocrinol (Paris) 2018;79:647-655. Epub 2018 Aug 16
Wong GW, Cheng PS. Increasing incidence of childhood Graves’ disease in Hong Kong: a follow-up study. Clin Endocrinol (Oxf) (Oxf) 2001;54:547-550.
Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol 1994;130:565-568.
Williamson S, Greene SA. Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland. Clin Endocrinol (Oxf) 2010;72:358-363. Epub 2009 Sep 21
Forssberg M, Arvidsson CG, Engvall J, Lindblad C, Snellman K, Aman J. Increasing incidence of childhood thyrotoxicosis in a population-based area of central Sweden. Acta Paediatr 2004;93:25-29.
Rodanaki M, Lodefalk M, Forssell K, Arvidsson CG, Forssberg M, Åman J. The Incidence of Childhood Thyrotoxicosis Is Increasing in Both Girls and Boys in Sweden. Horm Res Paediatr 2019;91:195-202.
Simon M, Rigou A, Le Moal J, Zeghnoun A, Le Tertre A, De Crouy-Chanel P, Kaguelidou F, Leger J. Epidemiology of Childhood Hyperthyroidism in France: A Nationwide Population-Based Study. J Clin Endocrinol Metab 2018;103:2980-2987.
Dydensborg S, Toftedal P, Biaggi M, Lillevang ST, Hansen DG, Husby S. Increasing prevalence of coeliac disease in Denmark: a linkage study combining national registries. Acta Paediatr 2012;101:179-184. Epub 2011 Jul 22
Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, Pihoker C, Saydah S, Wagenknecht L; SEARCH for Diabetes in Youth Study. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med 2017;376:1419-1429.
Havgaard Kjær R, Smedegård Andersen M, Hansen D. Increasing Incidence of Juvenile Thyrotoxicosis in Denmark: A Nationwide Study, 1998-2012. Horm Res Paediatr 2015;84:102-107. Epub 2015 Jun 24
